CTLA-4 antibody dosage escalation regimens

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9573999
APP PUB NO 20150246972A1
SERIAL NO

14714775

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A disease or condition, such as cancer or an infectious disease, can be treated in a patient by administering a CTLA-4 antibody in an escalating dosage regimen until a partial or complete response is elicited in the patient or a pre-determined maximum dosage is reached.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
E R SQUIBB & SONS L L CROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08540

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lowy, Israel Dobbs Ferry, US 48 446
Nichol, Geoffrey M Short Hills, US 6 88

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 21, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00